326 filings
6-K
GMAB
Genmab
16 Apr 24
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2024
10:07am
6-K
GMAB
Genmab
15 Apr 24
Current report (foreign)
1:17pm
6-K
GMAB
Genmab
8 Apr 24
Current report (foreign)
1:41pm
6-K
GMAB
Genmab
3 Apr 24
Genmab to Broaden and Strengthen Oncology Portfolio with Acquisition of ProfoundBio
6:19am
6-K
GMAB
Genmab
2 Apr 24
Current report (foreign)
9:10am
6-K
hlvhf0s833fz0
25 Mar 24
Current report (foreign)
2:13pm
6-K
c7ej12op tagq5s
21 Mar 24
Current report (foreign)
3:28pm
6-K
mcdd ogrx
18 Mar 24
Completion of share buy-back program
4:37pm
6-K
qre 6mymu
15 Mar 24
Genmab Announces Initiation of Share Buy-Back Program
9:46am
6-K
8ijsx vqfophp1mn
13 Mar 24
Current report (foreign)
5:10pm
6-K
10ixuw5k
13 Mar 24
Passing of Genmab A/S’ Annual General Meeting
11:34am
6-K
bw1fp3r hqjhcmkg7fyx
11 Mar 24
Current report (foreign)
1:43pm
6-K
84dy1
4 Mar 24
Current report (foreign)
1:50pm
6-K
ctk qaccdnk6
4 Mar 24
Current report (foreign)
1:26pm
6-K
q5z b4hgo
1 Mar 24
Current report (foreign)
6:38pm
6-K
qy45g
29 Feb 24
Current report (foreign)
11:47am
6-K
1c269c0i7fhbf2hfzz8
28 Feb 24
Current report (foreign)
11:06am
6-K
90gu5wm29qxs60
27 Feb 24
Capital Increase in Genmab as a Result of Employee Warrant Exercise
4:55pm
6-K
2wv 38y6tf14kb7
26 Feb 24
Current report (foreign)
12:19pm
6-K
w23tfv9ipxaq5ca4y14y
26 Feb 24
Current report (foreign)
10:40am